世界のPOC分子診断市場2022年~2026年

【英語タイトル】Global POC Molecular Diagnostics Market 2022-2026

Technavioが出版した調査資料(IRTNTR45390-22)・商品コード:IRTNTR45390-22
・発行会社(調査会社):Technavio
・発行日:2022年5月4日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥320,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥384,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥512,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
テクナビオ社は、世界のPOC分子診断市場規模が2022年~2026年まで年平均14.67%成長し、18.3億ドルに達すると予測しています。本調査レポートは、POC分子診断の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(PCR、マイクロアレイ・ハイブリダイゼーション)分析、用途別(感染症、腫瘍、血液・内分泌、その他)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などを掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のPOC分子診断市場規模:製品別(PCR、マイクロアレイ・ハイブリダイゼーション)
・世界のPOC分子診断市場規模:用途別(感染症、腫瘍、血液・内分泌、その他)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析
【レポートの概要】

Global POC Molecular Diagnostics Market 2022-2026
Technavio has been monitoring the POC molecular diagnostics market and it is poised to grow by $ 1.83 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our report on the POC molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.
The POC molecular diagnostics market analysis includes the product, application segment, and geographic landscape.

Technavio’s POC molecular diagnostics market is segmented as below:

By Product
• PCR
• Microarray and hybridization

By Application
• Infectious diseases
• Oncology
• Hematology and endocrinology
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing focus on technological advances as one of the prime reasons driving the POC molecular diagnostics market growth during the next few years. Also, the presence of government funding and a growing number of cancer cases worldwide will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on POC molecular diagnostics market covers the following areas:
• POC molecular diagnostics market sizing
• POC molecular diagnostics market forecast
• POC molecular diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC molecular diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., Binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., gene drive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Also, the POC molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/poc-molecular-diagnostics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

【レポートの目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 14: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 24: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 25: Chart on Product – Market share 2021-2026 (%)
o Exhibit 26: Data Table on Product – Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 27: Chart on Comparison by Product
o Exhibit 28: Data Table on Comparison by Product
o 5.3 PCR – Market size and forecast 2021-2026
o Exhibit 29: Chart on PCR – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Data Table on PCR – Market size and forecast 2021-2026 ($ million)
o Exhibit 31: Chart on PCR – Year-over-year growth 2021-2026 (%)
o Exhibit 32: Data Table on PCR – Year-over-year growth 2021-2026 (%)
o 5.4 Microarray and hybridization – Market size and forecast 2021-2026
o Exhibit 33: Chart on Microarray and hybridization – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Data Table on Microarray and hybridization – Market size and forecast 2021-2026 ($ million)
o Exhibit 35: Chart on Microarray and hybridization – Year-over-year growth 2021-2026 (%)
o Exhibit 36: Data Table on Microarray and hybridization – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 37: Market opportunity by Product ($ million)
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 38: Chart on Application – Market share 2021-2026 (%)
o Exhibit 39: Data Table on Application – Market share 2021-2026 (%)
o 6.2 Comparison by Application
o Exhibit 40: Chart on Comparison by Application
o Exhibit 41: Data Table on Comparison by Application
o 6.3 Infectious diseases – Market size and forecast 2021-2026
o Exhibit 42: Chart on Infectious diseases – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on Infectious diseases – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on Infectious diseases – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on Infectious diseases – Year-over-year growth 2021-2026 (%)
o 6.4 Oncology – Market size and forecast 2021-2026
o Exhibit 46: Chart on Oncology – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Oncology – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Oncology – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Oncology – Year-over-year growth 2021-2026 (%)
o 6.5 Hematology and endocrinology – Market size and forecast 2021-2026
o Exhibit 50: Chart on Hematology and endocrinology – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Hematology and endocrinology – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Hematology and endocrinology – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Hematology and endocrinology – Year-over-year growth 2021-2026 (%)
o 6.6 Others – Market size and forecast 2021-2026
o Exhibit 54: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 6.7 Market opportunity by Application
o Exhibit 58: Market opportunity by Application ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 60: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 8.2 Geographic comparison
o Exhibit 62: Chart on Geographic comparison
o Exhibit 63: Data Table on Geographic comparison
o 8.3 North America – Market size and forecast 2021-2026
o Exhibit 64: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 65: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 66: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 67: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 8.4 Europe – Market size and forecast 2021-2026
o Exhibit 68: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 69: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 70: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 71: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 8.5 Asia – Market size and forecast 2021-2026
o Exhibit 72: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 73: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 74: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 75: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 8.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 76: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 77: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 78: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 79: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 8.7 US – Market size and forecast 2021-2026
o Exhibit 80: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 81: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 82: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 83: Data Table on US – Year-over-year growth 2021-2026 (%)
o 8.8 Germany – Market size and forecast 2021-2026
o Exhibit 84: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 85: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 86: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 87: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 8.9 Canada – Market size and forecast 2021-2026
o Exhibit 88: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 89: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 90: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 91: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 8.10 China – Market size and forecast 2021-2026
o Exhibit 92: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 93: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 94: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 95: Data Table on China – Year-over-year growth 2021-2026 (%)
o 8.11 France – Market size and forecast 2021-2026
o Exhibit 96: Chart on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 97: Data Table on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 98: Chart on France – Year-over-year growth 2021-2026 (%)
o Exhibit 99: Data Table on France – Year-over-year growth 2021-2026 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 100: Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2021 and 2026
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 105: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 11.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 11.4 bioMerieux SA
o Exhibit 112: bioMerieux SA – Overview
o Exhibit 113: bioMerieux SA – Business segments
o Exhibit 114: bioMerieux SA – Key offerings
o Exhibit 115: bioMerieux SA – Segment focus
o 11.5 Danaher Corp.
o Exhibit 116: Danaher Corp. – Overview
o Exhibit 117: Danaher Corp. – Business segments
o Exhibit 118: Danaher Corp. – Key news
o Exhibit 119: Danaher Corp. – Key offerings
o Exhibit 120: Danaher Corp. – Segment focus
o 11.6 F. Hoffmann La Roche Ltd.
o Exhibit 121: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 122: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 123: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 124: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 125: F. Hoffmann La Roche Ltd. – Segment focus
o 11.7 QIAGEN NV
o Exhibit 126: QIAGEN NV – Overview
o Exhibit 127: QIAGEN NV – Product / Service
o Exhibit 128: QIAGEN NV – Key news
o Exhibit 129: QIAGEN NV – Key offerings
o 11.8 QuantuMDx Group Ltd.
o Exhibit 130: QuantuMDx Group Ltd. – Overview
o Exhibit 131: QuantuMDx Group Ltd. – Product / Service
o Exhibit 132: QuantuMDx Group Ltd. – Key offerings
o 11.9 Quidel Corp.
o Exhibit 133: Quidel Corp. – Overview
o Exhibit 134: Quidel Corp. – Product / Service
o Exhibit 135: Quidel Corp. – Key offerings
o 11.10 Robert Bosch GmbH
o Exhibit 136: Robert Bosch GmbH – Overview
o Exhibit 137: Robert Bosch GmbH – Business segments
o Exhibit 138: Robert Bosch GmbH – Key news
o Exhibit 139: Robert Bosch GmbH – Key offerings
o Exhibit 140: Robert Bosch GmbH – Segment focus
o 11.11 Siemens AG
o Exhibit 141: Siemens AG – Overview
o Exhibit 142: Siemens AG – Business segments
o Exhibit 143: Siemens AG – Key news
o Exhibit 144: Siemens AG – Key offerings
o Exhibit 145: Siemens AG – Segment focus
o 11.12 Thermo Fisher Scientific Inc.
o Exhibit 146: Thermo Fisher Scientific Inc. – Overview
o Exhibit 147: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 148: Thermo Fisher Scientific Inc. – Key news
o Exhibit 149: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 150: Thermo Fisher Scientific Inc. – Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 151: Inclusions checklist
o Exhibit 152: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 153: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 154: Research methodology
o Exhibit 155: Validation techniques employed for market sizing
o Exhibit 156: Information sources
o 12.5 List of abbreviations
o Exhibit 157: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits18: Five forces analysis – Comparison between2021 and 2026
Exhibits19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits21: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits22: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits23: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits24: Chart on Market condition – Five forces 2021 and 2026
Exhibits25: Chart on Product – Market share 2021-2026 (%)
Exhibits26: Data Table on Product – Market share 2021-2026 (%)
Exhibits27: Chart on Comparison by Product
Exhibits28: Data Table on Comparison by Product
Exhibits29: Chart on PCR – Market size and forecast 2021-2026 ($ million)
Exhibits30: Data Table on PCR – Market size and forecast 2021-2026 ($ million)
Exhibits31: Chart on PCR – Year-over-year growth 2021-2026 (%)
Exhibits32: Data Table on PCR – Year-over-year growth 2021-2026 (%)
Exhibits33: Chart on Microarray and hybridization – Market size and forecast 2021-2026 ($ million)
Exhibits34: Data Table on Microarray and hybridization – Market size and forecast 2021-2026 ($ million)
Exhibits35: Chart on Microarray and hybridization – Year-over-year growth 2021-2026 (%)
Exhibits36: Data Table on Microarray and hybridization – Year-over-year growth 2021-2026 (%)
Exhibits37: Market opportunity by Product ($ million)
Exhibits38: Chart on Application – Market share 2021-2026 (%)
Exhibits39: Data Table on Application – Market share 2021-2026 (%)
Exhibits40: Chart on Comparison by Application
Exhibits41: Data Table on Comparison by Application
Exhibits42: Chart on Infectious diseases – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on Infectious diseases – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on Infectious diseases – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on Infectious diseases – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Oncology – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Oncology – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Oncology – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Oncology – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Hematology and endocrinology – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Hematology and endocrinology – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Hematology and endocrinology – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Hematology and endocrinology – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits58: Market opportunity by Application ($ million)
Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits60: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits62: Chart on Geographic comparison
Exhibits63: Data Table on Geographic comparison
Exhibits64: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits65: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits66: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits67: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits68: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits69: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits70: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits71: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits72: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits73: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits74: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits75: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits76: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits77: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits78: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits79: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits80: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits81: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits82: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits83: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits84: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits85: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits86: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits87: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits88: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits89: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits90: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits91: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits92: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits93: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits94: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits95: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits96: Chart on France – Market size and forecast 2021-2026 ($ million)
Exhibits97: Data Table on France – Market size and forecast 2021-2026 ($ million)
Exhibits98: Chart on France – Year-over-year growth 2021-2026 (%)
Exhibits99: Data Table on France – Year-over-year growth 2021-2026 (%)
Exhibits100: Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2021 and 2026
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: bioMerieux SA – Overview
Exhibits113: bioMerieux SA – Business segments
Exhibits114: bioMerieux SA – Key offerings
Exhibits115: bioMerieux SA – Segment focus
Exhibits116: Danaher Corp. – Overview
Exhibits117: Danaher Corp. – Business segments
Exhibits118: Danaher Corp. – Key news
Exhibits119: Danaher Corp. – Key offerings
Exhibits120: Danaher Corp. – Segment focus
Exhibits121: F. Hoffmann La Roche Ltd. – Overview
Exhibits122: F. Hoffmann La Roche Ltd. – Business segments
Exhibits123: F. Hoffmann La Roche Ltd. – Key news
Exhibits124: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits125: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits126: QIAGEN NV – Overview
Exhibits127: QIAGEN NV – Product / Service
Exhibits128: QIAGEN NV – Key news
Exhibits129: QIAGEN NV – Key offerings
Exhibits130: QuantuMDx Group Ltd. – Overview
Exhibits131: QuantuMDx Group Ltd. – Product / Service
Exhibits132: QuantuMDx Group Ltd. – Key offerings
Exhibits133: Quidel Corp. – Overview
Exhibits134: Quidel Corp. – Product / Service
Exhibits135: Quidel Corp. – Key offerings
Exhibits136: Robert Bosch GmbH – Overview
Exhibits137: Robert Bosch GmbH – Business segments
Exhibits138: Robert Bosch GmbH – Key news
Exhibits139: Robert Bosch GmbH – Key offerings
Exhibits140: Robert Bosch GmbH – Segment focus
Exhibits141: Siemens AG – Overview
Exhibits142: Siemens AG – Business segments
Exhibits143: Siemens AG – Key news
Exhibits144: Siemens AG – Key offerings
Exhibits145: Siemens AG – Segment focus
Exhibits146: Thermo Fisher Scientific Inc. – Overview
Exhibits147: Thermo Fisher Scientific Inc. – Business segments
Exhibits148: Thermo Fisher Scientific Inc. – Key news
Exhibits149: Thermo Fisher Scientific Inc. – Key offerings
Exhibits150: Thermo Fisher Scientific Inc. – Segment focus
Exhibits151: Inclusions checklist
Exhibits152: Exclusions checklist
Exhibits153: Currency conversion rates for US$
Exhibits154: Research methodology
Exhibits155: Validation techniques employed for market sizing
Exhibits156: Information sources
Exhibits157: List of abbreviations



【掲載企業】

Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, Quidel Corp.

★調査レポート[世界のPOC分子診断市場2022年~2026年] (コード:IRTNTR45390-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のPOC分子診断市場2022年~2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆